Canada Pension Plan Investment Board
CRBP icon

Canada Pension Plan Investment Board’s Corbus Pharmaceuticals CRBP Stock Holding History

Canada Pension Plan Investment Board’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$116K Hold
12,400
– – ﹤0.01% 1660
2026
Q1 		$116K Buy
+12,400
New +$104K ﹤0.01% 1643
2024
Q4 		– Sell
-26,000
Closed -$536K – 1425
2024
Q3 		$536K Buy
+26,000
New +$1.33M ﹤0.01% 1040

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Canada Pension Plan Investment Board's CRBP Position: Q2 2026 in Review

Canada Pension Plan Investment Board held its Corbus Pharmaceuticals (CRBP) position steady in Q2 2026 at 12,400 shares worth $116K. The position accounts for ﹤0.01% of the portfolio, ranked #1660.

Canada Pension Plan Investment Board first reported a position in CRBP in Q3 2024 and has held it in 3 quarters since. The position peaked at $536K in Q3 2024. 107 funds tracked by Wall St. Rank hold CRBP as of Q2 2026.

  • Canada Pension Plan Investment Board held 12,400 shares of Corbus Pharmaceuticals worth $116K as of Q2 2026.
  • Canada Pension Plan Investment Board left its Corbus Pharmaceuticals share count unchanged in Q2 2026.
  • Corbus Pharmaceuticals made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #1660 holding.
  • Canada Pension Plan Investment Board first reported a position in Corbus Pharmaceuticals in Q3 2024 and has held it in 3 quarters since.
  • Canada Pension Plan Investment Board's Corbus Pharmaceuticals position peaked at $536K in Q3 2024.
  • 107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.